Logo image of YOU.DE

ABOUT YOU HOLDING SE (YOU.DE) Stock Fundamental Analysis

FRA:YOU - Deutsche Boerse Ag - DE000A3CNK42 - Common Stock - Currency: EUR

6.7  -0.01 (-0.15%)

Fundamental Rating

3

Taking everything into account, YOU scores 3 out of 10 in our fundamental rating. YOU was compared to 55 industry peers in the Specialty Retail industry. YOU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. YOU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

YOU had negative earnings in the past year.
YOU had a positive operating cash flow in the past year.
In the past 5 years YOU always reported negative net income.
In multiple years YOU reported negative operating cash flow during the last 5 years.
YOU.DE Yearly Net Income VS EBIT VS OCF VS FCFYOU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

YOU has a worse Return On Assets (-9.88%) than 78.18% of its industry peers.
YOU has a Return On Equity of -60.08%. This is amonst the worse of the industry: YOU underperforms 81.82% of its industry peers.
Industry RankSector Rank
ROA -9.88%
ROE -60.08%
ROIC N/A
ROA(3y)-13.02%
ROA(5y)-12.53%
ROE(3y)-54.84%
ROE(5y)-58.79%
ROIC(3y)N/A
ROIC(5y)N/A
YOU.DE Yearly ROA, ROE, ROICYOU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

YOU's Gross Margin of 42.86% is fine compared to the rest of the industry. YOU outperforms 65.45% of its industry peers.
In the last couple of years the Gross Margin of YOU has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for YOU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-0.73%
YOU.DE Yearly Profit, Operating, Gross MarginsYOU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 -10 20 30 40

4

2. Health

2.1 Basic Checks

YOU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, YOU has more shares outstanding
The number of shares outstanding for YOU has been increased compared to 5 years ago.
YOU has a worse debt/assets ratio than last year.
YOU.DE Yearly Shares OutstandingYOU.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
YOU.DE Yearly Total Debt VS Total AssetsYOU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.51 indicates that YOU is not a great score, but indicates only limited risk for bankruptcy at the moment.
YOU has a better Altman-Z score (2.51) than 67.27% of its industry peers.
The Debt to FCF ratio of YOU is 3.30, which is a good value as it means it would take YOU, 3.30 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of YOU (3.30) is better than 83.64% of its industry peers.
YOU has a Debt/Equity ratio of 0.91. This is a neutral value indicating YOU is somewhat dependend on debt financing.
YOU has a worse Debt to Equity ratio (0.91) than 65.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 3.3
Altman-Z 2.51
ROIC/WACCN/A
WACC6.78%
YOU.DE Yearly LT Debt VS Equity VS FCFYOU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

YOU has a Current Ratio of 1.06. This is a normal value and indicates that YOU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.06, YOU is in line with its industry, outperforming 41.82% of the companies in the same industry.
A Quick Ratio of 0.45 indicates that YOU may have some problems paying its short term obligations.
With a Quick ratio value of 0.45, YOU is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.45
YOU.DE Yearly Current Assets VS Current LiabilitesYOU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

YOU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.20%, which is quite good.
YOU shows a small growth in Revenue. In the last year, the Revenue has grown by 3.44%.
YOU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.91% yearly.
EPS 1Y (TTM)8.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.52%
Revenue 1Y (TTM)3.44%
Revenue growth 3Y4.95%
Revenue growth 5Y21.91%
Sales Q2Q%8.66%

3.2 Future

Based on estimates for the next years, YOU will show a very strong growth in Earnings Per Share. The EPS will grow by 33.76% on average per year.
The Revenue is expected to grow by 8.52% on average over the next years. This is quite good.
EPS Next Y60.02%
EPS Next 2Y42.44%
EPS Next 3Y33.76%
EPS Next 5YN/A
Revenue Next Year8.37%
Revenue Next 2Y8.07%
Revenue Next 3Y6.23%
Revenue Next 5Y8.52%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
YOU.DE Yearly Revenue VS EstimatesYOU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
YOU.DE Yearly EPS VS EstimatesYOU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for YOU. In the last year negative earnings were reported.
Also next year YOU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YOU.DE Price Earnings VS Forward Price EarningsYOU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, YOU is valued a bit more expensive than the industry average as 70.91% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of YOU is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.61
EV/EBITDA 844.54
YOU.DE Per share dataYOU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as YOU's earnings are expected to grow with 33.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.44%
EPS Next 3Y33.76%

0

5. Dividend

5.1 Amount

YOU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ABOUT YOU HOLDING SE

FRA:YOU (7/11/2025, 7:00:00 PM)

6.7

-0.01 (-0.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-15 2025-07-15
Inst Owners1.69%
Inst Owner ChangeN/A
Ins Owners7.29%
Ins Owner ChangeN/A
Market Cap1.25B
Analysts50
Price Target6.63 (-1.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.33%
Min EPS beat(2)-101.84%
Max EPS beat(2)59.17%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-5.3%
Max Revenue beat(2)2.23%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-100.8%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.62
P/FCF 19.61
P/OCF 12.46
P/B 7.02
P/tB 15.06
EV/EBITDA 844.54
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.34
FCFY5.1%
OCF(TTM)0.54
OCFY8.03%
SpS10.75
BVpS0.95
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.88%
ROE -60.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.86%
FCFM 3.18%
ROA(3y)-13.02%
ROA(5y)-12.53%
ROE(3y)-54.84%
ROE(5y)-58.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-0.73%
F-Score4
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 3.3
Debt/EBITDA 107.27
Cap/Depr 51.55%
Cap/Sales 1.82%
Interest Coverage N/A
Cash Conversion 6673.33%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.45
Altman-Z 2.51
F-Score4
WACC6.78%
ROIC/WACCN/A
Cap/Depr(3y)55.42%
Cap/Depr(5y)85.38%
Cap/Sales(3y)1.89%
Cap/Sales(5y)1.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.52%
EPS Next Y60.02%
EPS Next 2Y42.44%
EPS Next 3Y33.76%
EPS Next 5YN/A
Revenue 1Y (TTM)3.44%
Revenue growth 3Y4.95%
Revenue growth 5Y21.91%
Sales Q2Q%8.66%
Revenue Next Year8.37%
Revenue Next 2Y8.07%
Revenue Next 3Y6.23%
Revenue Next 5Y8.52%
EBIT growth 1Y22.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year218.53%
EBIT Next 3Y62.71%
EBIT Next 5Y51.27%
FCF growth 1Y412.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y109.41%
OCF growth 3YN/A
OCF growth 5YN/A